Literature DB >> 1625199

Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.

C C Chao1, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang, P K Peterson.   

Abstract

Opiates modulate a variety of immune responses by peripheral blood mononuclear cells (PBMC). In the present study, we investigated the effect of morphine on the release of several cytokines upon stimulation with mitogens. An interleukin (IL)-4-dependent HT-2 cell proliferation assay was used to quantify transforming growth factor-beta (TGF-beta). IL-6 and tumor necrosis factor-alpha (TNF-alpha) were measured by enzyme-linked immunosorbent assays. Morphine (1 pM and 10 nM) alone did not significantly modulate the release of TGF-beta, IL-6 or TNF-alpha. Upon stimulation with lipopolysaccharide and phytohemagglutinin, PBMC released more (P less than .01) TGF-beta, IL-6 and TNF-alpha than unstimulated PBMC. Exposure of PBMC to morphine (1 pM) for 24 hr substantially amplified (P less than .05) the release of TGF-beta in the following 24 hr incubation period. Morphine did not alter the release of immunodetectable IL-6 or TNF-alpha from stimulated cells. The amplifying effect of morphine on the release of TGF-beta was mediated through a naloxone-sensitive mechanism. Given the fact that TGF-beta has a potent immunosuppressive effect, morphine-potentiated release of TGF-beta from PBMC may be involved in the immunomodulatory activity ascribed to morphine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625199

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta.

Authors:  P C Singhal; A A Kapasi; N Franki; K Reddy
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

Review 3.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

4.  Immunoregulatory effects of morphine on human lymphocytes.

Authors:  M P Nair; S A Schwartz; R Polasani; J Hou; A Sweet; K C Chadha
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 5.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 6.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

7.  Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.

Authors:  Eva A Operskalski; Wendy J Mack; Howard D Strickler; Audrey L French; Michael Augenbraun; Phyllis C Tien; Maria C Villacres; LaShonda Y Spencer; Marina Degiacomo; Andrea Kovacs
Journal:  J Clin Virol       Date:  2008-02-20       Impact factor: 3.168

8.  Downregulation of constitutive and cytokine-induced complement 3 expression by morphine in rat astrocytes.

Authors:  Chung Su Kim; Justin Sangwook Ko; Ae Ryoung Lee; Byung Seop Shin; Soo Joo Choi; Jeong Jin Lee; Hyun Soo Kim; Sangmin Maria Lee
Journal:  Curr Ther Res Clin Exp       Date:  2011-02

9.  Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.

Authors:  Albert Stuart Reece
Journal:  Subst Abuse       Date:  2012-09-27

10.  Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide.

Authors:  Prati Pal Singh; Priya Singal
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-10       Impact factor: 7.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.